For the Third Year in a row, Zuber Lawler Earns #1 Spot in Law360’s 2023 Diversity Snapshot Survey
August 1, 2023 | Press
Zuber Lawler is proud to announce that for the third year in a row it has been ranked #1 in Law360’s 2023 Diversity Snapshot, which measures diversity in the equity ranks of law firms across the country, sharing the honor with three other law firms. Zuber Lawler also ranked in the top 10 out of all law firms participating in the survey nationwide based on the diversity of all partners and associates.
The 2023 law firm survey reveals slow progress in diversifying attorney ranks, with only 17% of firms meeting diversity benchmarks. By contrast, the majority of the occupants of Zuber Lawler’s leadership posts throughout the firm are likewise minorities.
“We are pleased to be named first in two categories listed in Law 360’s 2023 Diversity Snapshot. This recognition exemplifies how critical diversity is to Zuber Lawler,” stated Eileen Letts, the Chicago-based Chief Administrative Partner of the firm. “Our firm is committed to making sure we look like the world. We believe we are better lawyers when we welcome and embrace diversity and we will continue to do so.”
Zuber Lawler’s commitment to diversity is enhanced with the help of Ms. Letts, who is on the Board of Directors of the National Association of Minority and Women-Owned Law Firms (NAMWOLF). Ms. Letts also co-authored the acclaimed book “Left Out and Left Behind,” organized by the Long-Term Careers for Women in Law Initiative, and published by the American Bar Association.
Disclaimer: This content may be an attorney advertisement. The information provided on this page does not constitute legal advice. All information, content, and materials available in this post are for general informational purposes only, and might not be up to date. The content on this website is provided “as is,” and no representations are made that the content is free of error. Usage of this website or any resources contained within it does not create an attorney-client relationship between user and any author of relevant content (or any law firm or company of which the author might be a part). Readers of this content should contact their attorney to obtain advice with respect to any particular legal matter. Any and all liability with respect to actions taken or not taken based on the contents of this website are hereby expressly disclaimed.
Recent Updates
An FDA Panel Just Voted to Widen Access to Peptides. Here’s What It Actually Means for the Longevity Space July 30, 2026
Generative AI Legal Issues: 5 Critical Questions Every Business Must Answer Before Deploying AI Solutions May 21, 2026
Medical Rescheduling, Recreational Risk: How Schedule III Could Reshape Adult-Use Cannabis February 18, 2026
Schedule III Cannabis: FDA’s New Frontier January 27, 2026
Data Privacy and AI in Longevity: Legal Risks Around Predictive Biomarkers and Health Data January 23, 2026
2026 Employment Law Developments: Key Takeaways for Employers December 22, 2025